Involvement of low adiponectin levels in impaired glucose tolerance

Metabolism: Clinical and Experimental

Volumn 57, Issue 10, 2008, Pages 1350-1354

  Nakashima, Youhei ^a   Inukai, Kouichi ^a   Imai, Kenta ^a   Ikegami, Yuichi ^a   Awata, Takuya ^a   Katayama, Shigehiro ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE;

ADULT; AGE DISTRIBUTION; AGED; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; LIPID DIET; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SEX DIFFERENCE;

ADIPONECTIN; ADULT; AGED; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; REGRESSION ANALYSIS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51649118843     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.05.001     Document Type: Article

References (29)

1. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
2. Hotamisligil G.S. The roles of TNFa and TNF receptors in obesity and insulin resistance. J Intern Med 245 (1999) 621-625
3. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., and Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221 (1996) 286-289
4. Shimomura I., Funahashi T., Takahashi M., Maeda K., Kotani K., Nakamura T., et al. Enhanced expression of PAI-1 in visceral fat; possible contributor to vascular disease in obesity. Nat Med 2 (1996) 800-803
5. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
6. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8 (2002) 731-737
7. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 (1997) 610-614
8. Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., et al. Regulation of fasted blood glucose by resistin. Science 303 (2004) 1195-1198
9. Arita Y., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 247 (1999) 79-83
10. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kurihara H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
11. Kondo H., Shimomura I., Matsukawa Y., Kumada M., Takahashi M., Matsuda M., et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 51 (2002) 2325-2328
12. Berg A.H., Combs T.P., Du X., Brownlee M., and Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7 (2001) 947-953
13. Combs T.P., Berg A.H., Obici S., Scherer P.E., and Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108 (2001) 1875-1881
14. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed, Erickson M.R., Yen F.T., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98 (2001) 2005-2010
15. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., Matsui J., et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277 (2002) 25863-25866
16. Yamauchi T., Kamon J., Waki H., Imai Y., Shimozawa N., Hioki N., et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278 (2003) 2461-2468
17. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
18. Anai M., Funaki M., Ogihara T., Kanda A., Onishi Y., Sakoda H., et al. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high fat fed rats. Diabetes 48 (1999) 158-169
19. Shimomura I., Hammer R.E., Richardson J.A., Ikemoto S., Bashmakov Y., Goldstein J.L., et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 12 (1998) 3182-3194
20. Inukai K., Nakashima Y., Watanabe M., Takata N., Sawa T., Kurihara S., et al. Regulation of adiponectin receptor gene expression in diabetic mice. Am J Physiol Endocrinol Metab 288 (2005) E876-E882
21. Abbasi F., Chu J.W., Lamendola C., McLaughlin T., Hayden J., Reaven G.M., et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53 (2004) 585-590
22. Kawano T., Saito T., Yasu T., Saito T., Nakamura T., Namai K., et al. Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease. Metabolism 54 (2005) 653-656
23. Hashimoto N, Kanda J, Nakamura T, Horie A, Kurosawa H, Hashimoto T, et al. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenosis. Metabolism 55:1653-1657.
24. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 22 (1999) 920-924
25. The DECODE Study Group, European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354 (1999) 617-621
26. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001) 941-946
27. Yoon M.J., Lee G.Y., Chung J.J., Ahn Y.H., Hong S.H., and Kim J.B. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase and peroxisome proliferator-activated receptor a. Diabetes 55 (2006) 2562-2570
28. Shklyaev S., Aslanidi G., Tennant M., Prima V., Kohlbrenner E., Kroutov V., et al. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci U S A 100 (2003) 14217-14222
29. Satoh H., Nguyen M.T.A., Trujillo M., Imamura T., Usui I., Scherer P.E., et al. Adenovirus-mediated adiponectin expression augments skeletal muscle insulin sensitivity in male Wistar Rats. Diabetes 54 (2005) 1302-1313